Optimization of Pulsed Electromagnetic Field (PEMF) Dosimetry in ACL Injuries Using the Taguchi Design Method

PEMF Dosimetry optimization in ACL injuries using the Taguchi design method - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102129

Enrollment

Registered

2026-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S835- Sprain of cruciate ligament of knee

Interventions

Intervention1: Pulsed Electromagnetic Field Therapy: Pulsed Electromagnetic Field (PEMF) therapy is a non-invasive, non-thermal electrotherapeutic modality that utilizes low-frequency electromagnetic

Eligibility

Inclusion criteria

Inclusion criteria: 1 Clinically and or MRI confirmed Grade II ACL injury 2 Symptom duration 3 Willingness to participate and provide informed consent

Exclusion criteria

Exclusion criteria: 1 Grade III ACL tears or history of ACL reconstruction. 2 Associated ligament or meniscal tears requiring surgery. 3 Contraindications to PEMF (pacemakers metal implants pregnancy epilepsy malignancy infection at site 4 Recent corticosteroid injection

Design outcomes

Primary

Measure	Time frame
Pain: VAS change from baseline to Week 4. Function: IKDC subjective score change from baseline to Week 4.Timepoint: Baseline to 4 weeks	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDr Sanjib Kumar Das

Amity

skdas@amity.edu8879485847

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026